← Research library

Synthetic peptide TEKKRRETVEREKE derived from ezrin induces differentiation of NIH/3T3 fibroblasts.

Lab research · 2017

What was studied
NIH/3T3 mouse fibroblasts, including CD44-knockout cells
Main finding
The defined TEKKRRETVEREKE peptide promoted differentiation-related changes through ERK1/2 signaling without SMAD activation.

Study data at a glance

Participants or experimental model
NIH/3T3 mouse fibroblasts, including CD44-knockout cells
Reported results
The defined TEKKRRETVEREKE peptide promoted differentiation-related changes through ERK1/2 signaling without SMAD activation.
Study limitations and source details

Study limitations

  • Cell signaling does not quantify wound healing in patients.
  • Full methods, reporting completeness and independent replication remain to be appraised.

Source details

Original journal report

Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.

Abstract reviewed

Sources checked

Citation

In vitroEnglish abstract

Chulkina M, Negmadjanov U, Lebedeva E, Pichugin A, Mazurov D, Ataullakhanov R, Holmuhamedov E. Synthetic peptide TEKKRRETVEREKE derived from ezrin induces differentiation of NIH/3T3 fibroblasts. European journal of pharmacology · PMID 28668507

Study source ↗ · DOI 10.1016/j.ejphar.2017.06.033 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards